Featured Viewpoint on Understanding the Challenges of Biosimilar Medicines

As major biological medicines currently on the market approach the end of their patent protection, drug manufacturers around the world are exploring the possibility of producing “generic” biopharmaceuticals – known as “biosimilars” or “follow-on proteins” – that would increase the availability and lower the p...